Summary Canine transmissible venereal sarcoma (CTVS) is a naturally occurring contagious neoplasm which can be transplanted with intact viable cells across major histocompatibility (MHC) barriers within the species and even to other members of the canine family, such as foxes, coyotes, and wolves. After 2 to 4 months of progressive growth the tumour regresses spontaneously in adults but metastasizes in immunosuppressed hosts and neonates. The mechanisms of how the tumour cells manage to overcome histocompatibility barriers so successfully for such a long period and yet succumb later are not known. In the present study we found that CTVS cells were not stimulatory to the lymphocytes of normal or tumourbearing animals in mixed lymphocyte-tumour reaction (MLTR), although the lymphocytes from tumourbearing hosts responded well to either phytohaemagglutinin (PHA) or third-party allogeneic lymphocytes. Immunofluorescent antibody (IFA) assay of MHC antigens by monoclonal antibodies (MoAb) to monomorphic Class I and Class II MHC antigens showed that progressor tumour cells lacked the expression of the antigens whereas 30 to 40% of regressor tumour cells expressed them.
Canine transmissible venereal sarcoma (CTVS) is probably which most CTVS cells were not viable following collagenese the only known instance of natural, successful transdigestion. plantation of allogeneic cells (Moulton, 1978; Gross, 1983;  The tumour grows equally in both males and females and Cohen, 1985) . It is transmitted via intact viable cells as a thus dogs of both sexes were used in the experiment. stem-line through coition among dogs of various parts of the Collagenase (Grade 1, Sigma Chemicals Co., St. Louis, world (Makino, 1963; Weber et al., 1965) . After 2 to 4 MO, USA) dissociated tumour cells in 0.02% sodium azide months of progressive growth, the tumour regresses spontanwere used in immunofluorescent (IF) assay for membrane eously in adults but metastasizes in immunosuppressed dogs antigens whereas cells from tumours minced with scissors (Cohen, 1973) and neonates (Yang & Jones, 1973) . The were used in mixed lymphocyte-tumour reaction (MLTR) mechanisms of how the tumour cells manage to overcome studies. Both progressor and regressor tumour cells were histocompatibility barriers so successfully for such a long used in IF assay but, due to the difficulty in obtaining period and yet succumb later are not known.
enough cells from regressors, only progressor tumours were In this communication we present evidence that lack of used in MLTR. expression of major histocompatibility complex (MHC) antiFor MLTR assay, mechanically dispersed CTVS cells were gens may be responsible, at least in part, for 'universal take' washed four to five times and suspended to 1 to 5 x 107 and progressive growth of CTVS in allogeneic hosts. cells ml-in 7 to 10 ml of Hanks' balanced salt solution (HBSS). The suspension (5 ml) was layered over a linear Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) Materials and methods density gradient, modified from that described by Ulmer & Flad (1979) . For preparation of the gradient, 9 ml of Percoll Tumour cells was mixed with 1 ml of lOX HBSS, pH 5.0, and made into a linear gradient with 1X HBSS, pH 7.4. The growth patterns of the tumour were classified addition, appropriate controls such as mitomycin-C treated 'progressor', a tumour that was steadily increasing in responder cells were also included. volume; 'steady state', a tumour that was neither increasing For mitomycin C (MC) treatment, lymphocytes (2 x 106 or decreasing significantly in volume; 'early regressor', a cells ml-1) and tumour cells (1 x 106 cells ml 1) were treated tumour that was decreasing rapidly in volume andl in which with 25 ygml 1 of MC (Sigma), according to the protocol of most CTVS cells were viable following collagenase digestion; Waithe & Hirschorn (1973) .
and 'late regressor', a tumour in which the volume was For the assays, responder cells from tumour-bearing decreasing slowly following a period of rapid decline in animals and controls were added to stimulator cells at a 1:1 ratio for peripheral blood lymphocytes and 2:1 ratio for lymph node cells. Appropriate control cultures were estab-
lished with the same cell ratios. After incubation of mixed Received 6August 1986; and in revised form70October 1986.
cultures at 37°C for 6 days they were pulsed with 3[H]-thymidine for 14 to 16 h and processed for scintillation the draining (prescapular) ( (Trail & Yang, 1985) . The number of MHC Class I and Class II antigen positive cells remained the same after overnight culture, indicating that they were expressed, and not adsorbed, antigens.
Discussion
Impressed by the intriguing theoretical problems posed by this tumour (the canine transmissible venereal sarcoma), the late Dr P.A. Gorer suggested in 1960 that 'were it not for the antigenic diversity of most species and the existence of a mechanism to react against the antigen, contagious tumors would be relatively common' (Beer & Billingham, 1976) . In this experiment we presented evidence to support that CTVS is indeed the experiment of nature for a successful mammalian cell parasite. The progressively growing CTVS cells were not stimulatory to the lymphocytes from tumourbearing (secondary response) and normal (primary response) hosts in MLTR. In contrast, lymphocytes from the peripheral blood and the draining lymph nodes of tumourbearing animals reacted equally, or nearly so, as those of normal controls in the third-party MLR (Table II) Hess et al. (1975) , they did not consider that contaminating lymphocytes were responsible and the contrasting results remain an enigma.
Our findings on the lack of expression of Class I antigens (Table III) on progressor tumours confirm and substantiate the finding of Cohen et al. (1984) who showed that CTVS cells lack fl2-microglobulin expression. Since expression of the a chains of Class I antigens on the cell surface depends on the presence of /32-microglobulins, we do not know whether the lack of expression of Class I antigens on CTVS is due to the absence of a chain product and/or f2-microglobulin. In contrast, 32% of regressor tumour cells were Class I antigen positive, confirming the results of Epstein & Bennett (1974) who studied the CTVS cell lines obtained from Dr D. Cohen. The difference in results obtained by Cohen et al. (1984) and Epstein & Bennett (1974) from the same lines of CTVS cells remains unknown.
The polymorphic phenotypes of the Class I and Class II MHC antigens which are expressed on regressing CTVS need to be investigated further.
Although CTVS cells have been shown previously to be coated with immunoglobulin during the progressive phase of tumour growth (Cohen, 1972; Bennett et al., 1975; Beschorner et al., 1979) , the collagenase-dissociated and washed tumour cells used in this study were found to be free of immunoglobulin coating as assayed by immunofluorescence assay, indicating that the failure to demonstrate MHC antigens on progressively growing tumours was not due to masking of tumour cells with immunoglobulins.
We feel that lack of expression of Class I and Class II MHC antigens on progressor tumour cells as shown in this study, shedding of tumour-associated antigen (Palker & Yang, 1981; Palker et al., 1986 [manuscript in preparation]), formation of immune complexes (Palker & Yang, 1985) , and production of blocking factors Beschorner et al., 1979) may be mechanisms responsible for CTVS to escape recognition (Beer & Billingham, 1976) and to block hosts' immune system (Alexander, 1974; Harding & Yang, 1985) and grow progressively in allogeneic hosts. In contrast, as substantiated by recent experimental demonstration of reversal of oncogenesis by the expression of MHC Class I gene in adenovirus-12 transformed mouse cells (Tanaka et al., 1985) , expression of Class I and Class II MHC antigens on regressor tumour cells observed in this study and the changes in tumour cell types from round to spindle-shaped 'transitional' cells (Kennedy et al., 1977; Hill et al., 1984) suggest that induction of cell differentiation by the product (e.g. lymphokines) of infiltrating lymphocytes (Yang et al., 1976) , especially T-cells (Chandler & Yang, 1981; Trail & Yang, 1985) may be important in spontaneous tumour regression.
